Prognosis of coronary stent thrombosis: Difference between revisions
Jump to navigation
Jump to search
Smitakohli (talk | contribs) New page: The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent throm... |
Smitakohli (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent thrombosis was associated with death or myocardial infarction in 89% (186/210) of patients<ref name="pmid18377975">{{cite journal |author=Wiviott SD, Braunwald E, McCabe CH, ''et al.'' |title=Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial |journal=Lancet |volume=371 |issue=9621 |pages=1353–63 |year=2008 |month=April |pmid=18377975 |doi=10.1016/S0140-6736(08)60422-5 |url=}}</ref>. | The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent thrombosis was associated with death or myocardial infarction in 89% (186/210) of patients<ref name="pmid18377975">{{cite journal |author=Wiviott SD, Braunwald E, McCabe CH, ''et al.'' |title=Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial |journal=Lancet |volume=371 |issue=9621 |pages=1353–63 |year=2008 |month=April |pmid=18377975 |doi=10.1016/S0140-6736(08)60422-5 |url=}}</ref>. In follow up studies after stent thrombosis, recurrent stent thrombosis has also been noticed, especially during the following six months<ref name="pmid19232197">{{cite journal |author=Gallego L, Martínez-Sellés M, García E, ''et al.'' |title=Characteristics and outcome of angiographically confirmed stent thrombosis |journal=Rev Esp Cardiol |volume=62 |issue=2 |pages=220–3 |year=2009 |month=February |pmid=19232197 |doi= |url=}}</ref>. | ||
Revision as of 17:18, 21 December 2009
The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent thrombosis was associated with death or myocardial infarction in 89% (186/210) of patients[1]. In follow up studies after stent thrombosis, recurrent stent thrombosis has also been noticed, especially during the following six months[2].
References
- ↑ Wiviott SD, Braunwald E, McCabe CH; et al. (2008). "Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial". Lancet. 371 (9621): 1353–63. doi:10.1016/S0140-6736(08)60422-5. PMID 18377975. Unknown parameter
|month=ignored (help) - ↑ Gallego L, Martínez-Sellés M, García E; et al. (2009). "Characteristics and outcome of angiographically confirmed stent thrombosis". Rev Esp Cardiol. 62 (2): 220–3. PMID 19232197. Unknown parameter
|month=ignored (help)